Ki Seong Ko
Inventor
Stats
- 0 US patents issued
- 5 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 0 US Patents Issued
- 5 US Applications Filed
- 17 Total Citation Count
- Dec 13, 2019 Most Recent Filing
- Dec 27, 2013 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
CHONG KUN DANG PHARMACEUTICAL CORP. | 2
| 2013
|
INDUSTRY-ACADEMIC COOPERATION FOUNDATION GYEONGSANG NATIONAL UNIVERSITY | 1
| 2017
|
Inventor Addresses
Address | Duration |
---|---|
Gyeonggi-do, KR | Oct 15, 15 - Feb 24, 22 |
Gyeongsangnam-do, KR | May 18, 17 - Mar 12, 19 |
Technology Profile
Technology | Matters | |
---|---|---|
A01H: | NEW PLANTS OR PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES | 1 |
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 5 |
C07K: | PEPTIDES | 1 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
2022/0054,508 | 2022 | COMPOSITION COMPRISING DUTASTERIDE | 0 |
10722585 | 2020 | Sustained-release lipid pre-concentrate of GNRH analogues and pharmaceutical composition comprising the same | 0 |
10227604 | 2019 | Plant synthesizing hypoallergenic paucimannose type N-glycan and uses thereof | 0 |
2018/0207,146 | 2018 | PHARMACEUTICAL COMPOSITION COMPRISING 5ALPHA-REDUCTASE INHIBITOR | 6 |
2017/0137,837 | 2017 | PLANT SYNTHESIZING HYPOALLERGENIC PAUCIMANNOSE TYPE N-GLYCAN AND USES THEREOF | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.